Cardiovascular diseases (CVDs) are pointed out by the World Health Organization (WHO)
as the leading cause of death, contributing to a significant and growing global health and …

Background In recent years, cardiovascular disease in particular myocardial infarction (MI)
has become the predominant cause of human disability and mortality in the clinical setting …

Cardiovascular disease is the leading cause of mortality and morbidity worldwide. Despite
improvements in the standard of care for patients with heart diseases, including innovation …

Introduction Acute myocardial infarction (AMI) remains a leading cause of death in the
United States. The limited capacity of cardiomyocytes to regenerate and the restricted …

Background Mesenchymal stromal cell (MSC) transplantation can improve the left
ventricular ejection fraction (LVEF) after an acute myocardial infarction (AMI). Transplanted …

Background Stem cell transplantation is an emerging therapy for severe cardiomyopathy,
proffering stem cell recruitment, anti-apoptosis, and proangiogenic capabilities. Angiogenic …

Cell therapy is an important topic in the field of regeneration medicine that is gaining
attention within the scientific community. However, its potential for treatment in coronary …

Background Microvascular obstruction (MVO) is associated with greater infarct size, adverse
left-ventricular (LV) remodeling and reduced ejection fraction following ST-elevation …

Purpose Heart failure (HF) is a major complication of acute myocardial infarction (AMI).
Transplantation of bone marrow mononuclear cells (BM-MNC) in the setting of AMI has been …

Ischaemic heart disease (IHD) remains the leading cause of mortality worldwide. Current
pharmaceutical treatments focus on delaying, rather than preventing disease progression …